HPLC ASSAY OF MODEL TABLET FORMULATIONS CONTAINING METRONIDAZOLE AND CIPROFLOXACIN

Authors

  • Vania Maslarska Medical University of Sofia, Faculty of Pharmacy, Department of Chemistry, 2 Dunav st., 1000 Sofia, Bulgaria
  • Boyka Tsvetkova
  • Lily Peikova
  • Bistra Kostova
  • Dimitar Rachev
  • Stanislav Bozhanov
  • Nelina Zareva

Keywords:

Metronidazole, Ciprofloxacin, RP-HPLC, validation, model tablet formulations, quality control

Abstract

Objective: This paper describes development and validation of a high-performance liquid chromatographic analytical procedure for simultaneously determination of metronidazole and ciprofloxacin in a model tablet formulations.

Methods: The separation was achieved with a LiChrosorb® RP-18 (250 x 4.6 mm) column, at 33 °C temperature with isocratic mode and a mobile phase containing triethylamine: o-phosphoric acid and аcetonitrile (0.02:80:20 v/v/v). The flow rate was 1.0 ml/min and the eluent was monitored at 290 nm.

Results: The selected chromatographic conditions were found to separate effectively metronidazole and ciprofloxacin with a retention time of 3.46 min and 6.68 min, respectively. The method was validated for analytical parameters specificity, linearity, precision, accuracy, LOD and LOQ. The calibration curves were linear in the concentration range of 12.5-100.0 µg/ml for metronidazole and ciprofloxacin. The recovery for metronidazole and ciprofloxacin was 100.1 % and 100.2 %, respectively.

Conclusion: The analytical procedure was applied to quality control of model tablet formulations. It was established that the developed analytical procedure was successfully used for routine analysis of metronidazole and ciprofloxacin in model tablet dosage forms without any interference from included excipients.

Keywords: Metronidazole, Ciprofloxacin, RP-HPLC, Validation, Model tablet formulations, Quality control

Downloads

Download data is not yet available.

References

Fairclough PD, Silk DBA. Clinical medicine. In: Kumar P, Clark M. editors. Gastrointestinal disease. 7th ed. Amsterdam: Elsevier; 2005. p. 241-359.

Sweetman SC. Martindale the complete drug reference. 35th ed. London, Chicago: The Pharmaceutical Press; 2007.

Beale JM. Wilson and Gisvold’s textbook of organic medicinal and pharmaceutical chemistry. In: Block JH, Beale JM. Editors. Antibacterial Antibiotics. 11th ed. Philadelphia: Lippincott Williams and Wilkins; 2004. p. 258-330.

Welk R, Schneider L. Ciprofloxacin in combination with metronidazole. Infection 1988;16:257-60.

Hafez H, Elshanawany A, Abdelaziz L, Mohram M. Design of experiment utilization to develop a simple and robust RP-UPLC technique for stability indicating the method of ciprofloxacin hydrochloride and metronidazole in tablets. Eur J Anal Chem 2015;10:84-105.

Elkady EF, Mahrouse MA. Reversed-phase ion-pair HPLC and TLC-densitometric methods for the simultaneous determination of ciprofloxacin hydrochloride and metronidazole in tablets. Chromatographia 2011;73:297–305.

Vega E, Dabbene V, Nasseta M, Sola N. Validation of a reversed-phase LC method for quantitative analysis of intravenous admixtures of ciprofloxacin and metronidazole. J Pharm Biomed 1999;21:1003–9.

Khadabadi SS, Devkar MG. A validated RP-HPLC method for simultaneous estimation of metronidazole and ciprofloxacin hydrochloride in pharmaceutical dosage form. Int J Pharm Sci Res 2013;4:4736-40.

Patel A, Shah N, Patel N. Simultaneous estimation of metronidazole and ciprofloxacin by RP-HPLC method in bulk drug and suspension. Int J Chem Sci 2009;7:2115-21.

Ramzia I, Asma A, Ehab E, Maha M, Asma M. Stability indicating HPLC method for the simultaneous determination of ciprofloxacin hydrochloride and metronidazole in the presence of ciprofloxacin acid degradation product. Asian J Biochem Pharm Res 2015;5:5-17.

Piponski M, Bakovska T, Naumoska M, Rusevska T, Serafimovska G, Andonovska H. Preliminary investigation of the possibility for implementation of modified pharmacopoeial HPLC methods for quality control of metronidazole and ciprofloxacin in medicinal products used in veterinary medicine. Maced Vet Rev 2015;38:31-42.

Mahrouse M, Elkady E. Validated spectrophotometric methods for the simultaneous determination of ciprofloxacin hydrochloride and metronidazole in tablets. Chem Pharm Bull 2011;59:1485-93.

Mahrouse M. Development and validation of a UV spectrophotometric method for the simultaneous determination of ciprofloxacin hydrochloride and metronidazole in a binary mixture. J Chem Pharm Res 2012;4:4710-5.

Natesh G. A new analytical method development and validation for estimation of ciprofloxacin and metronidazole by isoabsorption method by using UV spectrophotometer. J Chem Biol Phys Sci 2013;3:1663-70.

Chadha R, Aggarwal A, Jain DVS, Kapoor VK, Thakur D, Sharma A. Degradation kinetics of metronidazole and its mutual prodrug with ciprofloxacin: a calorimetric analysis. Int J Biol Chem Sci 2007;1:197-210.

Vega E, Sola N. Quantitative analysis of metronidazole in intravenous admixture with ciprofloxacin by first derivative spectrophotometry. J Pharm Biomed 2001;25:523-30.

Reinscheid U. Direct determination of ciprofloxacin in admixtures with metronidazole and ampicillin by NMR. J Pharm Biomed 2006;40:447-9.

International Conference on Harmonization (2005) ICH harmonized tripartite guideline Validation of analytical procedures: text and methodology Q2 (R1) ICH, Geneva, Nov; 2005.

Published

01-05-2016

How to Cite

Maslarska, V., B. Tsvetkova, L. Peikova, B. Kostova, D. Rachev, S. Bozhanov, and N. Zareva. “HPLC ASSAY OF MODEL TABLET FORMULATIONS CONTAINING METRONIDAZOLE AND CIPROFLOXACIN”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 5, May 2016, pp. 306-10, https://journals.innovareacademics.in/index.php/ijpps/article/view/11222.

Issue

Section

Original Article(s)